Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx “Underuse” Is PhRMA Focus For 2004; Agenda Includes Uninsured, Imports

Executive Summary

The Pharmaceutical Research & Manufacturers of America hopes to shift attention in 2004 away from high drug prices to the "underuse" of medications

You may also be interested in...



PhRMA Adds Depression Awareness To Communications Efforts

The Pharmaceutical Research & Manufacturers of America is highlighting the costs of depression in the workplace as part of its 2004 theme on the "underuse" of prescription drugs

PhRMA Adds Depression Awareness To Communications Efforts

The Pharmaceutical Research & Manufacturers of America is highlighting the costs of depression in the workplace as part of its 2004 theme on the "underuse" of prescription drugs

“Together Rx” Will Stand Apart From Medicare Drug Cards; Lilly Plans Role

The "Together Rx" discount card program will help in the enrollment process for Medicare-endorsed Rx cards but will not seek endorsement for its own program

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel